Left Atrial Appendage Occlusion in High Bleeding Risk Patients

Table 2

Antithrombotic therapy before and after left atrial appendage closure.

	Pretreatment	Posttreatment, discharge	Posttreatment, 3 months	Posttreatment, 6/12 months
n	68	68	68	62
No antithrombotic therapy	16 (23.5%)	5 (7.3%)	10 (14.7%)	20 (32.3%)
Single anti-platelet therapy	12 (17.7%)	29 (42.7%)	40 (58.9%)	34 (54.8%)
Dual anti-platelet therapy	23 (33.8%)	32 (47.1%)	16 (23.5%)	8 (12.9%)
Anticoagulant therapy	17 (25.0%)	2 (2.9%)	2 (2.9%)	0 (0.0%)